Quality Investor

Guardian Pharmacy Services, Inc.

Rank #39Op. Leverage

GRDN · NYSE · Healthcare

Guardian Pharmacy Services, Inc. (GRDN) — Rank #39 by gross profitability (GP/assets 0.66) · ROE 19.1% · Piotroski F-Score N/A.

As-of 2026-09-15 · CIK 0001802255 · all metrics point-in-time as of the filing date.

About

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.

Show more

The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc.

was founded in 2003 and is headquartered in Atlanta, Georgia.

Industry
Medical Care Facilities
Sector
Healthcare
State
GA
Filer Category
Accelerated filer
Fiscal Year End
December 31

Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.

USD in millions, except per-share (EPS) and percentage rows. Values are as originally filed; em-dash = not tagged in that year's filing.
Fiscal year end2025-12-31filed 2026-03-112024-12-31filed 2026-03-11
Assets
Liabilities
Equity

Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?